Related Experiment Video
Updated: May 10, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
Wenlin Wu1, Jie Hong1, Yanping Ran1
1Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou City, Guangdong Province, China.
Insights
Ofatumumab (OFA) offers a safe and effective treatment for pediatric anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. This anti-CD20 antibody therapy improved symptoms and achieved B cell depletion in patients resistant to initial treatments.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a severe autoimmune neurological disorder.
- Pediatric patients often face challenges with first-line immunotherapy, necessitating alternative treatment strategies.
Abstract:
Ofatumumab (OFA) is an anti-CD20 antibody. We assessed the therapeutic potential of OFA in five pediatric anti-NMDAR encephalitis patients who showed poor responses to the first-line immunotherapy. OFA treatment showed clinical improvement including alleviation of clinical symptoms and mRS decrease accompanied by anti-NMDAR antibody turning negative in 3 patients and decline in 2 patients. And all patients achieved B cell depletion after OFA treatment. During follow-up, all patients' symptoms were stable. OFA treatment is safe and effective, easy to administer, and favorable for pediatric anti-NMDAE encephalitis patients who are refractory to the first-line immunotherapy.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology